Vlaams Instituut Voor Biotechnologie - Flanders Institute

Vlaams Instituut Voor Biotechnologie - Flanders Institute

Vlaams Instituut Voor Biotechnologie - Flanders Institute

Overview
Date Founded

1995

Headquarters

Rijvisschestraat 120,Ghent, Flemish Region 9052

Company Description

Vlaams Instituut voor Biotechnologie - Flanders Institute operates as a non-profit organization, provides research and development services. It specializes in translating basic scientific results into pharmaceutical, agricultural and industrial applications. The company was founded on January 1, 1996 and is headquartered in Ghent, Belgium.

Website
Executives & Employees

Chief Financial Officer

Vice Chairman

Managing Director

Co-Managing Director

Director-Human Resources

Professor of Molecular Medicine

Manager-Business Development

Subscribe now to see full list of current and former executives
Board of Directors

Board of Trustees-Term Trustees at Carnegie Mellon University

Vice Chairman at Vlaams Instituut Voor Biotechnologie - Flanders Institute

Chief Financial Officer & Managing Director at Biocartis SA

Chairman, Chief Executive Officer & Head-Investor Relations at ERYTECH Pharma SA

Chief Executive Officer at Gerard van Acker BVBA

Managing Director at Viziphar Biosciences BVBA

Professor at Catholic University of Louvain

Delegate Manager at Bayer Bioscience NV

Professor at KU Leuven Research & Development

Coordinator-Strategic Research at University of Antwerp

Subscribe now to see full list of current and former board members
Distinguished Alumni
Hugo M. Levecke is now Former Mitglied des Vorstands at T Group AG
Subscribe now to see full list of distinguished alumni
Paths to Vlaams Instituut Voor Biotechnologie - Flanders Institute
Potential Connections via
Relationship Science
You
Vlaams Instituut Voor Biotechnologie - Flanders Institute
Clients

ImmunoVaccine, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of cancer immunotherapies and infectious disease vaccines. The company was founded by Warwick Kimmins and Brian Lowe on March 28, 2000 and is headquartered in Halifax, Canada.

ThromboGenics NV is a biopharmaceutical company, which engages in developing and commercializing medicines for the treatment of vitreo retinal diseases. It operates under JETREA (ocriplasmin) brand name. The company was founded in 1991 by Desire Collen and is headquartered in Leuven, Belgium.

Subscribe now to see clients for over 2.5 million organizations
Subscribe now to see clients for over 2.5 million organizations
Investments
Details Hidden

AlgoNomics NV provided integrated immunogenicity services for the biopharmaceutical industry. The company's products included Epibase, Epibase-IV, and Tripole. It was founded by Philippe Stas and Ignace Lasters in 1999 and was headquartered in Gent, Belgium.

Details Hidden

Aphea.bio SA engages in research and development of biotechnology and agricultural products. It develops next generation biopesticides and biostimulants based on natural microorganisms. The company was founded by Isabel Vercauteren and Steven Vandenabeele in December 5, 2016 and is headquartered in Ghent, Belgium.

Details Hidden

AgroSavfe NV develops sustainable crop protection products. Its Agrobodies technology controls leaves, seeds, fruits, pests, and particular structures for enabling the targeted delivery and retention of the active ingredients to prevent and control weeds, pests, and diseases. The company was founded by Peter Verheesen in January 2013 and is headquartered in Ghent, Belgium.

Subscribe now to see full investment details